In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Biomarkers Study group

of the Acute Cardiovascular Care Association

The study group on biomarkers was part of the Working Group on Acute Cardiac Care of the European Society of Cardiology(ESC) and was integrated into the Acute Cardiovascular Care Association (ACCA) in August 2012.
The study group has been restructured in April 2013.

Founded by Prof. Kristian Thygesen, and now chaired by Prof. Bertil Lindhal, this group of experts is focusing on the proper clinical application of cardiac biomarkers including troponins, natriuretic peptides, and inflammatory and thrombotic markers in acute cardiac care.

Study group leadership

LindahlBertil Lindhal (SW)

ThygesenKristian Thygesen (DE)
(study group founder)

Study group members

  • Alan Jaffe - USA
  • Christian Mueller - CH
  • Johannes Mair - AT
  • Kurt Huber - AT
  • Martin Moeckel - GE
  • Evangelos Giannitsis - GE


  • To disseminate knowledge about proper clinical application of cardiac biomarkers in acute cardiac care. 
  • To advise on appropriate application of biomarkers in cardiovascular research. 
  • To promote opportunities for composing guidelines for implementation of cardiac biomarkers in acute cardiac care.
  • To be a counseling source for authorities regarding appropriate clinical use of cardiac biomarkers.

Activities & Achievements & future projects



2014 - 2015

2014 - Excellence in Acute Cardiac Care !! Event webcasts:

The event organised by Radiometer Medical Aps and supported by ACCA provided an opportunity to hear some of the most prominent names in the field of cardiac biomarker testing deliver an insight into the latest advances in this critical sector, and how they have been successful.


Future project and publications :

  • How to use test of platelet function in acute cardiac care.
  • How to use D-dimer, ACT, APTT and PK-INR in acute cardiac care.
  • Update on troponins

In addition, the study group will be engaged in several other educational activities during the next two years.